Acquisitions & PartnershipsBiomaterialsBioprinting

Biogelx and 3DBS partner to bring complete bioprinting solutions to Brazilian market

Scottish bioprinting company Biogelx has announced a partnership with 3D Biotechnology Solutions (3DBS), a Brazil-based manufacturer of bioprinting and electrospinning technologies. The companies will work together, combining their respective expertise to offer complete, tissue-specific bioprinting solutions for the Brazilian market. The partnership will also see 3DBS distributing Biogelx-INK bioprinting materials in the region.

Biogelx is an interesting company within the bioprinting sphere: it is one of the leading developers and producers of synthetic peptide hydrogel materials. The company recently introduced a series of hydrogel-based bioinks, Biogelx-INKs, that are not only biocompatible and extremely versatile but also easily and reliably printable. The reliability, says the company, is thanks to the synthetic nature of the hydrogels.

Through its partnership with 3DBS, Biogelx is moving ahead with its international growth strategy in Brazil, aiming to bring its products to public and private research institutions as well as universities and research consortiums.

“Over the past six years, we have built a reputation as the leading synthetic 3D cell culture scaffold brand,” said Sandy Bulloch, Director of Strategic Alliances of Biogelx. “Working with 3DBS allows us to transform how we scale our business to provide a complete bioprinting platform for multiple cell culture applications. This collaboration will accelerate the pace of our bioprinting innovation to generate the next generation of 3D tissue models.

Biogelx 3DBS partnership Brazil

3DBS, for its part, specializes in tissue engineering and is helping to shape the future of regenerative medicine with its innovative bioprinting products, including the Reactor, Genesis and other 3D bioprinter models. The company’s overarching goal is to provide tissue generating technologies to enable the construction of living human tissues.

“At 3DBS, our vision is to be a significant contributor in the construction of  the future of regenerative medicine,” explained Pedro Massaguer, PhD, Co-Founder of 3DBS. “By enabling customers to work with Biogelx-INKs using our bioprinters such as Genesis, Reactor or Octopus, we are getting one step closer to our revolutionary goal. Together, we have the opportunity to deliver more tissue-specific like constructs for applications in regenerative medicine and drug discovery.”

The collaboration between the two bioprinting companies will not only aim to provide “complete, tissue-specific bioprinting solutions” but to enable Brazilian researchers to reduce lead times and costs by purchasing Biogelx-INKs directly from the new Brazilian distributor.


Tess Boissonneault

Tess Boissonneault moved from her home of Montreal, Canada to the Netherlands in 2014 to pursue a master’s degree in Media Studies at the University of Amsterdam. It was during her time in Amsterdam that she became acquainted with 3D printing technology and began writing for a local additive manufacturing news platform. Now based in France, Tess has over two and a half years experience writing, editing and publishing additive manufacturing content with a particular interest in women working within the industry. She is an avid follower of the ever-evolving AM industry.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*